1ESC Committe for Practice Guideline (CPG).Executive summary of the guidelines on the diagnosis and treatment of acute heart failure:the Task Force on Acute Heart Failure of the European Society of Cardiology[J].Eur Heart J,2005,26(4):384-416.
4Feil R,Lohmann SM,de Jonge H,et al.Cyclic GMP-dependent protein kinases and the cardiovascular system:insights from genetically modified mice[J].Circ Res,2003,93(10):907-916.
5Jensen KT,Carstens J,Pedersen EB.Effect of BNP on renal hemodynamics,tubular function and vasoactive hormones in humans[J].Am J Physiol,1998,274(1 Pt 2):F63-72.
6Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF).Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure:a randomized controlled trial[J].JAMA,2002,287(12):1531-1540.
二级参考文献20
1Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type nariuretic peptide in the emergency diagnosis of heart failure[J]. N Engl J Med, 2002,347 (3)161-167.
2Morrison LK, Harrison A,Krishnaswamy P,et al. Utility of arapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea[J]. J Am Coil Cardiol,2002, 39(2) :202-209.
3Ford CM, Pruitt R, Parker V, et al. CHF: Effects of cardiac rehabilitation and brain natriuretic peptide [J]. Nurse Practitioner, 2004, 29(3) :36-39.
4Munagala VK, Burnett JC Jr, Jrredfield MM, et al. The natriuretie peptides in cardiovascular medicine[J]. Curt Prob Cardiol, 2004,29(12) :707-769.
5Mcdonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction[J]. Lancet,1998,351(9095) ;9-13.
6Nielsen OW~ Mcdonagh TA, Robb SD, et al. Retrospective analysis of the cost-effectiveness of using plasma brain natfiuretie peptide in screening for left ventrieular systolic dysfunction in the general population[J]. J Am Coil Cardiol,2003,41(1): 113-120.
7Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death[J]. N Engl J Med, 2004,350(7):655-663.
8Smith H, Picketing RM, Struthers A, et al. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study [J]. BMJ, 2000, 320(7239) :906-908.
9Vasan RS, Benjamin EJ,Larson MG, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study[J]. JAMA, 2002,288(10):1252-1259.
10Lubien E, Demaria A, Krishnaswamy P,et al. Utility of Bnatriuretic peptide in detecting diastolic dysfunction:comparison with Doppler velocity recordings[J]. Circulation,2002,105(5) :595-601.
